Published in:
Open Access
01-10-2014 | Original Article
A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey
Authors:
Ali Arican, Tulin Bozkurt, Hakan Bozcuk, Binnaz Demirkan, Suleyman Buyukberber, Necati Alkis, Ulus Ali Sanli, Celalettin Camci, Mustafa Yildiz, Idris Yucel, Kazim Uygun, Isik Aslay, Mutlu Demiray, Nuran Senel Bese, Abdurrahman Isikdogan, Zumrut Bahat, Cengiz Gemici, Feyyaz Ozdemir, Fatih Ozdener, Bahadir Pekin
Published in:
Supportive Care in Cancer
|
Issue 10/2014
Login to get access
Abstract
Purpose
This study aimed to report the practice of managing breast cancer with bone metastasis in Turkey and to determine the adherence to the British Association of Surgical Oncology (BASO) guidelines.
Methods
This multicenter, cross-sectional epidemiological survey was conducted in 38 centers across Turkey. Data from 1,026 breast cancer patients with bone metastases (mean age 54.0 ± 11.9 years) were analyzed.
Results
Over 30 % of patients had a diagnosis of metastatic breast cancer (stage IV) at the time of primary diagnosis. The imaging modalities used for diagnosing bone metastases were bone scintigraphy (57.8 %), radiography (22.8 %), and bone survey (4.4 %). Tumor markers were detected in 94.9 %, and markers of bone metabolism were measured in 90.4 % of patients. A total of 3.5 % of patients underwent surgery for bone metastasis, 26.4 % underwent palliative chemotherapy (most commonly docetaxel + capecitabine), and 56.5 % endured radiotherapy. Most patients (96 %) also received bisphosphonate. Radiography, bone scintigraphy, and CT were the main imaging tools used for postoperative follow-up of bone metastasis. Our results were >95 % in line with the BASO guidelines for the management of bone metastasis, except that interventional procedures, such as biopsy, were applied less frequently in our survey.
Conclusions
The diagnosis and management practices of breast cancer with bone metastasis in Turkey were generally compatible with international guidelines. However, the awareness and knowledge of physicians on the current guidelines should be increased, and equipment for the appropriate interventional procedures should be provided in every clinic to obtain optimal and standard management of bone metastases.